Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial.
Saraf A, Gurjar R, Kaviraj S, Kulkarni A, Kumar D, Kulkarni R, Virkar R, Krishnan J, Yadav A, Baranwal E, Singh A, Raghuwanshi A, Agarwal P, Savergave L, Singh S; GEMCOVAC-OM Study Investigators. Saraf A, et al. Among authors: gurjar r. Nat Med. 2024 May;30(5):1363-1372. doi: 10.1038/s41591-024-02955-2. Epub 2024 Apr 18. Nat Med. 2024. PMID: 38637636 Free PMC article. Clinical Trial.
Detection of preinvasive cancer cells.
Backman V, Wallace MB, Perelman LT, Arendt JT, Gurjar R, Müller MG, Zhang Q, Zonios G, Kline E, McGilligan JA, Shapshay S, Valdez T, Badizadegan K, Crawford JM, Fitzmaurice M, Kabani S, Levin HS, Seiler M, Dasari RR, Itzkan I, Van Dam J, Feld MS. Backman V, et al. Among authors: gurjar r. Nature. 2000 Jul 6;406(6791):35-6. doi: 10.1038/35017638. Nature. 2000. PMID: 10894529 No abstract available.
Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study.
Gurjar R, Dickinson L, Carr D, Stöhr W, Bonora S, Owen A, D'Avolio A, Cursley A, De Castro N, Fätkenheuer G, Vandekerckhove L, Di Perri G, Pozniak A, Schwimmer C, Raffi F, Boffito M; NEAT001/ANRS143 Study Group. Gurjar R, et al. Pharmacogenomics J. 2023 Jan;23(1):14-20. doi: 10.1038/s41397-022-00293-5. Epub 2022 Oct 20. Pharmacogenomics J. 2023. PMID: 36266537 Free PMC article.
MEN Type I (Wermer Syndrome).
Kaur G, Kulkarni A, Banka S, Gurjar R, Dhaka J, Prajapat R. Kaur G, et al. Among authors: gurjar r. J Assoc Physicians India. 2020 May;68(5):51-52. J Assoc Physicians India. 2020. PMID: 32610868
An International Comparison of Baseline Characteristics of Patients Undergoing Initiation of Anti-VEGF Therapy for DME.
Conti FF, Alezzandrini A, Rasendran C, Nakhwa C, Neves D, Queiroga FS, Chhablani J, Rocha J, Martins RP, Romero J, Wu L, Han M, Gurjar RK, Haq S, Lee S, Natarajan S, Ansari WH, Yoon YH, Singh RP; Global Diabetic Macular Edema Study Group. Conti FF, et al. Among authors: gurjar rk. Ophthalmic Surg Lasers Imaging Retina. 2019 Nov 1;50(11):e300-e310. doi: 10.3928/23258160-20191031-18. Ophthalmic Surg Lasers Imaging Retina. 2019. PMID: 31755982
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial.
Dickinson L, Gurjar R, Stöhr W, Bonora S, Owen A, D'Avolio A, Cursley A, Molina JM, Fäetkenheuer G, Vandekerckhove L, Di Perri G, Pozniak A, Richert L, Raffi F, Boffito M; NEAT001/ANRS143 Study Group. Dickinson L, et al. Among authors: gurjar r. J Antimicrob Chemother. 2020 Mar 1;75(3):628-639. doi: 10.1093/jac/dkz479. J Antimicrob Chemother. 2020. PMID: 31754703 Clinical Trial.
28 results